Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma

Endocrine Pathology

Volumn 17, Issue 4, 2006, Pages 345-354

  Sasano, Hironobu ^a   Suzuki, Takashi ^a   Moriya, Takuya ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal; Carcinoma; Cortex; Diagnosis; Histology; Immunohistochemistry; Pathology

Indexed keywords

MITOTANE; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER GRADING; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METASTASIS; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STEROIDOGENESIS;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; CELL COUNT; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MITOTIC INDEX; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 34347354300     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-006-0006-0     Document Type: Conference Paper

References (33)

1. Sasano N. Functional pathology of adrenocortical endocrine disorders. Trans Soc Pathol Jpn 64:31-54, 1975.
2. Sasano N, Sasano H. The adrenal cortex. In: Kovacs K, Asa SL, eds. Functional endocrine pathology. Oxford: Blackwell, 1998, 546-584.
3. Gandour MJ, Grizzle WE. A small adrenocortical carcinoma with aggressive behavior. An evaluation of criteria for malignancy. Arch Pathol Lab Med 110:1076-1079, 1986.
4. Hough AJ, Hollifield JW, Page DL, Hartmann WH. Prognostic factors in adrenal cortex tumors: a mathematical analysis of clinical and morphological data. Am J Clin Pathol 72:390-399, 1979.
5. Weiss LM. Comparable histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163-169, 1984.
6. Weiss LM, Medeiros LJ, Vickery AL. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202-206, 1989.
7. Sasano H, Suzuki T, Sano T, et al. Adrenocortical oncocytoma - a true nonfunctioning adrenocortical tumor. Am J Surg Pathol 15:949-956, 1991.
8. Hoang MP, Ayala AG, Albores-Saavedra J. Oncocytic adrenocortical carcinoma: a morphologic, immunohistochemical and ultrastructural study of four cases. Mod Pathol 15:973-978, 2002.
9. Wieneke JA, Thompson LDR, Heffess CS. Adrenal cortical neoplasms in the pediatric population. A clinicopathological and immunophenotypic analysis of 83 patients. Am J Surg Pathol 77:867-881, 2003.
10. Lack EE, Mulivihil JJ, Travis WD, et al. Adrenocortical neoplasms in the pediatric and adolescent age group. Clinicopathological study of 30 cases with emphasis on epidemiological and prognostic factors. Pathol Annu 27:1-53, 1992.
11. Mickalkiexicz EL, Sandrini R, Figueriredo B, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical registry. J Clin Oncol 22:838-845, 2004.
12. Stojadinovic A, Ghossein RA, Hoos A, et al. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 15:941-950, 2002.
13. Stratakis CA. Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metab 14:404-410, 2003.
14. Sidhu S, Gicquel C, Bambach CP, et al. Clinical and molecular aspects of adrenocortical tumorigenesis. ANZ J Surg 73:727-738, 2003.
15. Iino K, Sasano H, Yabuki N, et al. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. Mod Pathol 10:901-907, 1997.
16. Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Mod Pathol 11:1165-1170, 1998.
17. Martins ACP, Cologna AJ, Tucci S, et al. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms. J Urol 173:2138-2142, 2005.
18. Bernini GP, Moretti A, Viacava P, et al. Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues. Br J Cancer 86:1561-1565, 2002.
19. Wachenfeld C, Beuschlein F, Zwermann O, et al. Discerning malignancy in adrenocortical tumors: are molecular markers useful? Eur J Endocrinol 145:335-341, 2001.
20. Terzolo M, Boccuzzi A, Bovio S, et al. Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors. Urology 57:176-182, 2001.
21. Krishnamurthy S, Ordonez NG, Shelton TO, et al. Fine-needle aspiration cytology of a case of oncocytic adrenocortical carcinoma. Diagn Cytopathol 22:299-303, 2000.
22. Sasano H, Shizawa S, Nagura H. Adrenocortical cytopathology. Am J Clin Pathol 104:161-166, 1995.
23. Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169:5-11, 2003.
24. Harrison LE, Gaudin PB, Brennan MF. Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 134:181-185, 1999.
25. Hahner S, Fassnacht M. Mitotane for adrenocortical carcinoma treatment. Curr Opin Investig Drugs 6:386-394, 2005.
26. Berruti A, Terzolo M, Pia A, et al. Mitotane associated with etoposide, doxorubicin, and cisplatin in treatment of advanced adrenocortical carcinoma. Italian group study of adrenal cancer. Cancer 83:2194-2200, 1998.
27. Neville AM, O'Hare MJ. The human adrenal cortex. Berlin, Germany: Springer-Verlag, 1982.
28. Sasano H, Okamoto M, Sasano N. Immunohistochemical study of human adrenal cortex with mineralo- and glucocorticoid excess. Virchows Arch [A] 413:313-318, 1988.
29. Sasano H. Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocrine J 41:471-482, 1994.
30. Sasano H. New approaches in human adrenocortical pathology: assessment of adrenocortical function in surgical specimen of human adrenal glands. Endocr Pathol 3:4-13, 1992.
31. Tartour E, Caillou B, Tenenbaum F, et al. Immunohistochemical study of adrenocortical carcinoma: predictive value of the D11 monoclonal antibody. Cancer 72:3296-3303, 1993.
32. Sasano H, Shizawa S, Suzuki T, et al. Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy. Hum Pathol 26:1154-1156, 1995.
33. Takayama K, Sasano H, Fukaya T, et al. Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab. 80:2815-2821, 1995.